February 2016 FDA Recall Drug by Mylan Pharmaceuticals Inc.
D-0840-2016 - Failed Dissolution Specifications; three month stability time point.

This Class II drug recall was voluntarily initiated by Mylan Pharmaceuticals Inc. on February 12, 2016 for the product Drug. The FDA reported the reason for recall as failed dissolution specifications; three month stability time point.. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-0840-2016

Reason for Recall
Failed Dissolution Specifications; three month stability time point.
Initiated
02-12-2016
Reported
05-18-2016
Quantity
2928 bottles

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Mylan Pharmaceuticals Inc.
Paliperidone Extended-release Tablets, 1.5 mg, 30 count bottles, Rx only, Mylan Pharmaceuticals, Inc., Morgantown, WV --- NDC 0378-3978-93

Batch or Lot Expiration Information

Lot# Lot: 2005441, 01/2017, Code: 0378-3978-93